Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancer

R. K. Ismail*, J. van Breeschoten, M. W.J.M. Wouters, M. van Dartel, S. van der Flier, A. K.L. Reyners, P. de Graeff, A. M.G. Pasmooij, A. de Boer, K. E. Broekman, D. L. Hilarius

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancer'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science